The 2nd Annual Personalized Cancer Vaccine Summit returns to Boston as the only strategic forum dedicated to platforming the full spectrum of individualized cancer vaccines. With granular insights from early discovery and preclinical efforts through to the optimization of clinical and manufacturing strategies. Join 80+ CXOs, VPs, and Directors of Oncology, Immunotherapy, and Vaccine R&D from the field’s leading biopharma organizations to gain the insights and partners you require to translate your personalized vaccines and individualized immunotherapies into robust clinical candidates and commercially viable products for multiple tumor types.
